05.12.18: Capital Markets Day 2018

Bayer to drive value creation as company pursues ambitious growth targets through 2022Company strongly positioned to benefit from key megatrends / Through 2022, Bayer aims to grow sales by 4 percent, EBITDA before special items by 9 percent and free cash flow by 18 percent annually on average / Adjusted EBITDA margin targets for 2022: Crop Science to exceed 30 percent, Pharmaceuticals to hit more than 35 percent, and Consumer Health to reach approximately 24 percentmehr ...
Source: Bayer IR Newsfeed: Events - Category: Pharmaceuticals Source Type: news